Avanos Medical (NYSE:AVNS) announced today that it appointed David Pacitti as its new CEO, effective April 14, 2025.

List today: Avanos Medical AVNS is a medical technology company which offers infection prevention, surgical, respiratory, digestive health and pain management solutions. The Zacks Consensus Estimate ...

Medical announced the appointment of David Pacitti as its new CEO, effective April 14. Pacitti joins Avanos with a distinguished ...

Siemens Healthineers’ president of the Americas, David Pacitti, is leaving the imaging giant to become CEO of the devicemaker ...

Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025.

Avanos Medical named David Pacitti as its next chief executive officer, effective April 14. The medical technology company will pay Pacitti a base salary around $1.1 million and he would be eligible ...

An update from Avanos Medical ( ($AVNS) ) is now available. On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its ...

Highlights,Avanos Medical operates in the medical technology sector, specializing in advanced healthcare ...

Highlights,Avanos Medical’s stock recently witnessed a shift in analyst ratings from "buy" to "hold".,Institutional investors ...

Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.

Investors in Avanos Medical, Inc. AVNS need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2025 $10.00 Call had some of the highest ...